Skip to Main Content

Author Details

David A Moore
University College London Cancer Institute
2012
37
15
PMIDPaper TitleJournal TitlePublished Year
37258251Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.J Clin Pathol2024
36853169Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma.Cancer Res2023
37608772Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJ Pathol2023
37608771Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.J Pathol2023
37342197Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer.Front Oncol2023
36977461Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.Cancer Discov2023
34168072Prevalence and breakdown of EGFR exon 20 driver mutations in routine NHS lung cancer diagnostic testing.J Clin Pathol2022
35912165Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas.Res Rep Trop Med2022
36291791Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer Therapy.Cancers (Basel)2022
36156323Prevalence and breakdown of non-small cell lung cancer BRAF driver mutations in a large UK cohort.Lung Cancer2022
35091446Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma.Clin Cancer Res2022
33155719Inclusion of multiple high-risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma.Histopathology2021
33795785Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression.Sci Rep2021
34489586Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.Br J Cancer2021
34536732Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer.Lung Cancer2021
32129476The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.J Pathol2020
32879494Pervasive chromosomal instability and karyotype order in tumour evolution.Nature2020
30992300Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.Clin Cancer Res2019
31245058Prospective analysis of 895 patients on a UK Genomics Review Board.ESMO Open2019
30932019In situ growth in early lung adenocarcinoma may represent precursor growth or invasive clone outgrowth-a clinically relevant distinction.Mod Pathol2019
29113995Time for change: a new training programme for morpho-molecular pathologists?J Clin Pathol2018
30054375Analysis of a large cohort of non-small cell lung cancers submitted for somatic variant analysis demonstrates that targeted next-generation sequencing is fit for purpose as a molecular diagnostic assay in routine practice.J Clin Pathol2018
30076358Genomic instability in mutant p53 cancer cells upon entotic engulfment.Nat Commun2018
30154405Publisher Correction: Genomic instability in mutant p53 cancer cells upon entotic engulfment.Nat Commun2018
30108309Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.Sci Rep2018
29535826Circulating tumour-derived DNA in metastatic soft tissue sarcoma.Oncotarget2018
29258292Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.Nature2018
29152076Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.Oncotarget2017
28445469Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.Nature2017
28445112Tracking the Evolution of Non-Small-Cell Lung Cancer.N Engl J Med2017
28202521<i>Ex Vivo</i> Explant Cultures of Non-Small Cell Lung Carcinoma Enable Evaluation of Primary Tumor Responses to Anticancer Therapy.Cancer Res2017
26369632SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer.Clin Cancer Res2016
25959953The molecular approach to diagnosis in lung cancer.Br J Hosp Med (Lond)2015
26134170Duplex Ratio Tests as Diagnostic Biomarkers in Malignant Melanoma.J Mol Diagn2015
25141981Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer.Breast Cancer Res Treat2014
23810241Accurate detection of copy number changes in DNA extracted from formalin-fixed, paraffin-embedded melanoma tissue using duplex ratio tests.J Mol Diagn2013
21880059Prognostic tissue markers in melanoma.Histopathology2012
  • 1 - 37 of 37

Recommended Authors

Institut fur Pathologie, Universitatsklinikum Heidelberg
Career Start Year 2016
Number of shared co-authors 3
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2015
Number of shared co-authors 2
Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center
Career Start Year 2014
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2012
Number of shared co-authors 7
Nanjing Geneseeq Technology Inc.
Career Start Year 2012
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
University of Bern
Career Start Year 2009
Number of shared co-authors 6
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 4
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 0
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2007
Number of shared co-authors 2
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 8
Olivia Newton-John Cancer Research Institute
Career Start Year 2003
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 4
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 8
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2002
Number of shared co-authors 2
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 4
Monash University
Career Start Year 2000
Number of shared co-authors 3
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 3
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 2
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 7
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 5
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 7
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 1984
Number of shared co-authors 4
Broad Institute
Career Start Year 1983
Number of shared co-authors 4

Collaborators

Beatson Cancer Research Institute, University of Glasgow
Co-authored papers 12
Francis Crick Institute
Co-authored papers 10
University of Leicester
Co-authored papers 5
University Hospitals of Leicester NHS Trust
Co-authored papers 5
The Francis Crick Institute
Co-authored papers 4
The University of Manchester
Co-authored papers 4
University of Leicester
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Weill Cornell Medical College
Co-authored papers 3
University of Edinburgh
Co-authored papers 3
Co-authored papers 3
Yale University School of Medicine
Co-authored papers 3
Co-authored papers 3
Memorial Sloan-Kettering Cancer Center
Co-authored papers 2
Wellcome Sanger Institute
Co-authored papers 2
University of Cambridge
Co-authored papers 2
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers 2
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Stony Brook University
Co-authored papers 2
Radboud University Medical Center
Co-authored papers 2
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg
Co-authored papers 2
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
University Medical Center Utrecht
Co-authored papers 2
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 2
PSL University
Co-authored papers 2
Co-authored papers 2